COVID-19 and Candida duobushaemulonii superinfection: A case report
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier Masson s.r.l.
Abstract
Introduction: Critically ill COVID-19 patients are at high risk for nosocomial bacterial and fungal infections due to several predisposing factors such as intensive care unit stay, mechanical ventilation, and broad-spectrum antibiotics. Data regarding multidrug resistant (MDR) Candida species in COVID-19 patients is scarce, and nonexistent regarding Candida duobushaemulonii superinfections. Case description: A 34-year-old male presented to our institution with acute respiratory distress syndrome (ARDS) due to COVID-19 infection and developed Candida duobushaemulonii fungemia after multiple courses of antibiotics and prolonged mechanical ventilation. He died after recurrent pneumothorax led to respiratory failure and cardiac arrest. Discussion: Bacterial and fungal infections are common complications of viral pneumonia in critically ill patients. Data regarding these infections in COVID-19 patients has been poorly studied with only a few cases reporting secondary infection, mostly without identifying specific pathogens. Prolonged hospital stays, invasive interventions (central venous catheter, mechanical ventilation), and the use of broad-spectrum antibiotics in COVID-19 infections could carry a high risk of bacterial and/or fungal superinfections. Conclusion: Strategies to improve outcome in COVID-19 ICU patients should include early recognition of candidemia and appropriate antifungal therapy. © 2021 SFMM
Description
Keywords
Broad-spectrum antibiotics, Candida duobushaemulonii, Covid-19, Icu, Mechanical ventilation, Multidrug resistance, Adult, Antifungal agents, Candida, Candidemia, Fatal outcome, Humans, Male, Respiration, artificial, Respiratory distress syndrome, Saccharomycetales, Superinfection, Alteplase, Amikacin, Amphotericin b, Avibactam plus ceftazidime, C reactive protein, Carbapenem derivative, Caspofungin, Colistin, Cotrimoxazole, D dimer, Ferritin, Fluconazole, Flucytosine, Imipenem, Levofloxacin, Meropenem, Tigecycline, Voriconazole, Antifungal agent, Adult respiratory distress syndrome, Antibiotic resistance, Antibiotic sensitivity, Antifungal therapy, Article, Artificial ventilation, Bacterial pneumonia, Candida parapsilosis, Case report, Catheter infection, Clavispora lusitaniae, Clinical article, Computer assisted tomography, Coronavirus disease 2019, Death, Drug substitution, Drug withdrawal, Enterobacter cloacae, Heart arrest, Human, Hypotension, Intensive care unit, Intubation, Lung embolism, Minimum inhibitory concentration, Neutrophilia, Pneumothorax, Polymerase chain reaction, Respiratory failure, Sedation, Septic shock, Severe acute respiratory syndrome coronavirus 2, Stenotrophomonas maltophilia, Subarachnoid hemorrhage, Thrombocytosis, Urinary tract infection, Urine culture, Ventilator associated pneumonia, Budding yeast, Complication, Fatality